46L-28011-89320
3 vaccinations
3 coded responses
35 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 573 / SD
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-04-17
Registered in v-safe
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
-
2021-05-07
Dose 2 — Pfizer-BioNTech
- 2021-05-07
- 2021-05-08
-
2021-05-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-05-10
- 2021-05-11
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-08-06
-
2021-11-05
Survey response — 6 months, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Persistent moderate headaches. Currently trying to determine if it's a sleep position-related issue (such as my pillow needing adjustment) or if it's a seasonal change in a different environment.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Dose 3 — Pfizer-BioNTech
-
2022-01-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-13
- 2022-01-20
- 2022-01-27
-
2022-02-03
Survey response — day 28, dose 3MedDRA: Nasal discomfort, Secretion discharge, Sneezing — Feeling: GoodFree text: Sneezing and excessive mucus due to irritation in the right nostril. Seems to subside through the day. Can't pin down the cause and no other symptoms noticed.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-10
- 2022-02-17
-
2022-04-07
Survey response — 3 months, dose 3MedDRA: Cough, Exposure to SARS-CoV-2 — Feeling: FairFree text: Persistent mild cough after TDAP vaccine. May or may not have been influenced by exposure to COVID or previously administered COVID vaccine. Unknown if this is related but reporting it anyway.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Persistent moderate headaches. Currently trying to determine if it's a sleep position-related issue (such as my pillow needing adjustment) or if it's a seasonal change in a different environment.
Release 11 — day 28, dose 3
Symptoms: Sneezing and excessive mucus due to irritation in the right nostril. Seems to subside through the day. Can't pin down the cause and no other symptoms noticed.
Release 11 — 3 months, dose 3
Symptoms: Persistent mild cough after TDAP vaccine. May or may not have been influenced by exposure to COVID or previously administered COVID vaccine. Unknown if this is related but reporting it anyway.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal discomfort | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release